TimothyBarnes
08-21

$Alzamend Neuro, Inc(ALZN)$ My question is who would be selling when their is only 700K shares, and the news is not really the news.

The PTSD drug is nothing. However, it does increase the odds in the ad drug al002 from nothing to something. That something could very well be 200-1000 million. Sava with one ad drug in phase III is valued at 1000 million. So potential here is enormous because mcap is only 10 million now. So potential for 100X. When we get to phase III after december 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment